Franklin Biotechnology Discovery Fund A(acc)USD

Register to Unlock Ratings
Performance History30/04/2024
Growth of 1,000 (GBP) Advanced Graph
Franklin Biotechnology Discovery Fund A(acc)USD
Fund23.6-16.6-1.510.76.0
+/-Cat-2.4-7.66.412.09.8
+/-B’mrk-9.4-16.9-3.93.4-0.5
 
Key Stats
NAV
22/05/2024
 USD 40.64
Day Change -0.19%
Morningstar Category™ Sector Equity Biotechnology
ISIN LU0109394709
Fund Size (Mil)
30/04/2024
 USD 1625.86
Share Class Size (Mil)
22/05/2024
 USD 1259.75
Max Initial Charge 5.75%
Ongoing Charge
08/02/2023
  1.81%
Morningstar Research
Analyst Report13/10/2023
Katie Rushkewicz Reichart, Director
Morningstar, Inc

Franklin Biotechnology Discovery is overseen by experienced managers, but limited resources and an undifferentiated process earn the fund a Morningstar Analyst Rating of Neutral.This strategy’s compact team is composed of three managers who have...

Click here to read this analyst report on the underlying fund.
Morningstar Pillars
People23
Parent23
Process23
Performance
Price
Investment Objective: Franklin Biotechnology Discovery Fund A(acc)USD
The Fund’s investment objective is capital appreciation.
Returns
Trailing Returns (GBP)22/05/2024
YTD6.47
3 Years Annualised3.54
5 Years Annualised5.96
10 Years Annualised8.79
12 Month Yield 0.00
Management
Manager Name
Start Date
Evan McCulloch
01/11/2000
Wendy Lam
01/09/2018
Click here to see others
Inception Date
03/04/2000
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology TR USDMorningstar Gbl Biotechnology NR USD
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNot Specific
GrowthYes
IncomeNot Specific
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  Franklin Biotechnology Discovery Fund A(acc)USD30/04/2024
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stock98.380.0098.38
Bond0.000.000.00
Property0.000.000.00
Cash1.940.901.04
Other0.580.000.58
Top 5 Regions%
United States85.90
United Kingdom4.71
Europe - ex Euro4.19
Eurozone4.15
Canada1.05
Top 5 Sectors%
Healthcare98.89
Basic Materials1.11
Top 5 HoldingsSector%
Amgen IncHealthcareHealthcare7.08
Regeneron Pharmaceuticals IncHealthcareHealthcare6.34
Vertex Pharmaceuticals IncHealthcareHealthcare5.39
Ascendis Pharma A/S ADRHealthcareHealthcare4.07
AstraZeneca PLC ADRHealthcareHealthcare3.69
Franklin Biotechnology Discovery Fund A(acc)USD

Related

In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures